Organ-Specific Innate Immune Responses in a Mouse Model of Invasive Candidiasis

In a fatal mouse model of invasive candidiasis (IC), fungal burden changes with variable dynamics in the kidney, brain, spleen, and liver and declines in all organs except for the kidney, which inexorably loses function. Since leukocytes are required to control Candida, we hypothesized that differential leukocyte infiltration determines organ-specific outcome of the infection. We defined leukocyte accumulation in the blood, kidney, brain, spleen, and liver after infection using fluorescent-activated cell sorting (FACS) and immunohistochemistry. Accumulation of Ly6cintCD11b+ neutrophils predominated in all organs except the brain, where CD45intCD11b+CD11c– microglia were the major leukocytes detected, surrounding foci of invading Candida. Significantly more neutrophils accumulated in the spleen and liver than in the kidney during the first 24 h after infection, when neutrophil presence is critical for Candida control. Conversely, at later time points only the kidney continued to accumulate neutrophils, associated with immunopathology and organ failure. The distribution of neutrophils was completely different in each organ, with large abscesses exclusively forming in the kidney. Candida filamentation, an essential virulence factor, was seen in the kidney but not in the spleen or liver. IC induced Ly6chiCD11b+ inflammatory monocyte and NK1.1+ cell expansion in the blood and all organs tested, and MHCII+F4/80+CD11c– macrophage accumulation, mainly in the spleen and liver. This study is the first detailed analysis of leukocyte subsets accumulating in different target organs during IC. The results delineate immune responses to the same pathogen that are highly idiosyncratic for each organ tested. The work provides novel insights into the balance between effective host defense and immunopathology in IC.

[1]  T. Hohl,et al.  Monocyte-mediated defense against microbial pathogens. , 2008, Annual review of immunology.

[2]  C. Biron,et al.  A chemokine-to-cytokine-to-chemokine cascade critical in antiviral defense. , 2000, The Journal of clinical investigation.

[3]  P. Puccetti,et al.  Natural killer cells do not play a dominant role in CD4+ subset differentiation in Candida albicans-infected mice , 1993, Infection and immunity.

[4]  D. Herndon,et al.  Three different neutrophil subsets exhibited in mice with different susceptibilities to infection by methicillin-resistant Staphylococcus aureus. , 2004, Immunity.

[5]  R. Groszmann,et al.  Splanchnic and systemic hemodynamics in mice using a radioactive microsphere technique. , 1990, The American journal of physiology.

[6]  R. Krzesicki,et al.  Damage to pseudohyphal forms of Candida albicans by neutrophils in the absence of serum in vitro. , 1978, The Journal of clinical investigation.

[7]  K. Schuit,et al.  Phagocytosis and intracellular killing of pathogenic yeasts by human monocytes and neutrophils , 1979, Infection and immunity.

[8]  P. Ricciardi-Castagnoli,et al.  Dendritic Cells Discriminate between Yeasts and Hyphae of the Fungus Candida albicans , 2000, The Journal of experimental medicine.

[9]  R. Cholera,et al.  Chemokine receptor CCR5 promotes leukocyte trafficking to the brain and survival in West Nile virus infection , 2005, The Journal of experimental medicine.

[10]  J. Hamilton-miller,et al.  Effect of pH and osmolality on in vitro phagocytosis and killing by neutrophils in urine , 1993, Infection and immunity.

[11]  J. Lopez-Ribot,et al.  Use of a Genetically Engineered Strain To Evaluate the Pathogenic Potential of Yeast Cell and Filamentous Forms during Candida albicans Systemic Infection in Immunodeficient Mice , 2007, Infection and Immunity.

[12]  P. Mosci,et al.  Intracerebral transfer of an in vitro established microglial cell line: local induction of a protective state against lethal challenge with Candida albicans , 1991, Journal of Neuroimmunology.

[13]  A. Vázquez-Torres,et al.  Macrophages in resistance to candidiasis. , 1997, Microbiology and molecular biology reviews : MMBR.

[14]  G. Trinchieri,et al.  Neutrophil production of IL-12 and IL-10 in candidiasis and efficacy of IL-12 therapy in neutropenic mice. , 1997, Journal of immunology.

[15]  P. Puccetti,et al.  An immunoregulatory role for neutrophils in CD4+ T helper subset selection in mice with candidiasis. , 1997, Journal of immunology.

[16]  J. Papadimitriou,et al.  Neutrophil depletion increases susceptibility to systemic and vaginal candidiasis in mice, and reveals differences between brain and kidney in mechanisms of host resistance. , 1996, Microbiology.

[17]  S. Weiss Tissue destruction by neutrophils. , 1989, The New England journal of medicine.

[18]  P. Kincade,et al.  Inoculation candidiasis in a murine model of severe combined immunodeficiency syndrome , 1988, Infection and immunity.

[19]  J. Berlin,et al.  The epidemiology and attributable outcomes of candidemia in adults and children hospitalized in the United States: a propensity analysis. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[20]  P. Krause,et al.  Polymorphonuclear leukocyte heterogeneity in neonates and adults. , 1986, Blood.

[21]  M. Mack,et al.  Critical roles for CCR2 and MCP-3 in monocyte mobilization from bone marrow and recruitment to inflammatory sites. , 2007, The Journal of clinical investigation.

[22]  J. Berman,et al.  The distinct morphogenic states of Candida albicans. , 2004, Trends in microbiology.

[23]  M. Jutila,et al.  Elimination of mouse splenic macrophages correlates with increased susceptibility to experimental disseminated candidiasis. , 1994, Journal of immunology.

[24]  K. Garey,et al.  Time to initiation of fluconazole therapy impacts mortality in patients with candidemia: a multi-institutional study. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[25]  A. Sharpe,et al.  CD80+Gr-1+ Myeloid Cells Inhibit Development of Antifungal Th1 Immunity in Mice with Candidiasis1 , 2002, The Journal of Immunology.

[26]  D. MacCallum,et al.  Need for Early Antifungal Treatment Confirmed in Experimental Disseminated Candida albicans Infection , 2004, Antimicrobial Agents and Chemotherapy.

[27]  J. Papadimitriou,et al.  The pathogenesis of acute systemic candidiasis in a susceptible inbred mouse strain , 1986, The Journal of pathology.

[28]  Y. Imai,et al.  Macrophage/Microglia-specific Protein Iba1 Enhances Membrane Ruffling and Rac Activation via Phospholipase C-γ-dependent Pathway* , 2002, The Journal of Biological Chemistry.

[29]  G. Fink,et al.  Nonfilamentous C. albicans Mutants Are Avirulent , 1997, Cell.

[30]  H. Redmond,et al.  Macrophage-dependent candidacidal mechanisms in the murine system. Comparison of murine Kupffer cell and peritoneal macrophage candidacidal mechanisms. , 1993, Journal of immunology.

[31]  J. Cutler,et al.  Effect of mouse phagocytes on Candida albicans in in vivo chambers , 1981, Infection and immunity.

[32]  V. Perry,et al.  Turnover of resident microglia in the normal adult mouse brain , 1992, Neuroscience.

[33]  Andreas Diefenbach,et al.  RORγt and commensal microflora are required for the differentiation of mucosal interleukin 22–producing NKp46+ cells , 2009, Nature Immunology.

[34]  B. Hube,et al.  Candida albicans proteinases and host/pathogen interactions , 2004, Cellular microbiology.

[35]  S. Filler,et al.  Mice with disseminated candidiasis die of progressive sepsis. , 2005, The Journal of infectious diseases.

[36]  N. Van Rooijen,et al.  Ly6c+ “inflammatory monocytes” are microglial precursors recruited in a pathogenic manner in West Nile virus encephalitis , 2008, The Journal of experimental medicine.